Relation of Angiotensin-Converting Enzyme Inhibitor Treatment to Insulin-Like Growth Factor-1 Serum Levels in Subjects >65 Years of Age (the InCHIANTI Study)

American Journal of Cardiology

Volumn 97, Issue 10, 2006, Pages 1525-1529

  Maggio, Marcello ^a   Ceda, Gian Paolo ^b   Lauretani, Fulvio ^c   Pahor, Marco ^d   Bandinelli, Stefania ^e   Najjar, Samer S ^a   Ling, Shari M ^a   Basaria, Shehzad ^a,f   Ruggiero, Carmelinda ^a   Valenti, Giorgio ^b   Ferrucci, Luigi ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF PARMA   (Italy)

^c Tuscany Regional Health Agency   (Italy)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e Azienda Sanitaria di Firenze   (Italy)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SOMATOMEDIN C;

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; FEMALE; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERTENSION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; STROKE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; ITALY; LINEAR MODELS; MALE; TESTOSTERONE;

EID: 33646474121     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.11.089     Document Type: Article

References (19)

1. Brink M., Wellen J., and Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J Clin Invest 97 (1996) 2509-2516
2. Ceda G.P., Lauretani F., Russo C., Bartali B., Bandinelli S., Maggio M., Corsi A.M., Valle D., Valenti G., and Ferrucci L. The relationship between IGF-1 levels and physical performance in older men and women. the InCHIANTI study. Annu Meeting Endocrine Soc P2-475 (2003) 423
3. Barbieri M., Ferrucci L., Ragno E., Corsi A., Bandinelli S., Bonafe M., Olivieri F., Giovagnetti S., Franceschi C., Guralnik J.M., and Paolisso G. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 284 (2003) E481-E487
4. Song Y.H., Li Y., Du J., Mitch W.E., Rosenthal N., and Delafontaine P. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest 115 (2005) 451-458
5. Ferrucci L., Bandinelli S., Benvenuti E., Di Iorio A., Macchi C., Harris T.B., and Guralnik J.M. Subsystems contributing to the decline in ability to walk. bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 48 (2000) 1618-1625
6. Valenti G., Denti L., Maggio M., Ceda G.P., Volpato S., Bandinelli S., Ceresini G., Cappola A., Guralnik J.M., and Ferrucci L. Effect of DHEAS on skeletal muscle over the life span. the InCHIANTI study. J Gerontol A Biol Sci Med Sci 59 (2004) 466-472
7. Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., Guralnik J.M., and Longo D.L. The origins of age-related proinflammatory state. Blood 105 (2005) 2294-2299
8. Pisani P., Faggiano F., Krogh V., Palli D., Vineis P., and Berrino F. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol 26 suppl (1997) S152-S160
9. Simonsick E.M., Maffeo C.E., Rogers S.K., Skinner E.A., Davis D., Guralnik J.M., and Fried L. Methodology and feasibility of a home-based examination in disabled older women. the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci 52 (1997) M264-M274
10. Cushman D.W., Wang F.L., Fung W.C., Harvey C.M., and De Forrest J.M. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. Am J Hypertens 2 (1989) 294-306
11. Anwar A., Gaspoz J.M., Pampallona S., Zahid A.A., Sigaud P., Pichard C., Brink M., and Delafontaine P. Effect of congestive heart failure on the insulin-like growth factor-1 system. Am J Cardiol 90 (2002) 1402-1405
12. Corbalan R., Acevedo M., Godoy I., Jalil J., Campusano C., and Klassen J. Enalapril restores depressed circulating insulin-like growth factor 1 in patients with chronic heart failure. J Card Fail 4 (1998) 115-119
13. Onder G., Penninx B.W., Balkrishnan R., Fried L.P., Chaves P.H., Williamson J., Carter C., Di Bari M., Guralnik J.M., and Pahor M. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women. an observational study. Lancet 359 (2002) 926-930
14. Di Bari M., van de Poll-Franse L.V., Onder G., Kritchevsky S.B., Newman A., Harris T.B., Williamson J.D., Marchionni N., Pahor M., Health, and Aging and Body Composition Study. Antihypertensive medications and differences in muscle mass in older persons. the Health, Aging and Body Composition Study. J Am Geriatr Soc 52 (2004) 961-966
15. Farquharson C.A., and Struthers A.D. Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure. J Am Coll Cardiol 39 (2002) 767-775
16. van Kats J.P., Duncker D.J., Haitsma D.B., Schhuijt M.P., Niebuur R., Stubenitsky R., Boomsma F., Schalekamp M.A., Verdouw P.D., and Danser A.H. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction. role of tissue angiotensin II. Circulation 102 (2000) 1556-1563
17. MacFadyen R.J., Lee A.F., Morton J.J., Pringle S.D., and Struthers A.D. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?. Heart 82 (1999) 57-61
18. Kohlstedt K., Brandes R.P., Muller-Esterl W., Busse R., and Fleming I. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells. Circ Res 94 (2004) 60-67
19. Ignjatovic T., Tan F., Brovkovych V., Skidgel R.A., and Erdos E.G. Novel mode of action of angiotensin I converting enzyme inhibitors. direct activation of bradykinin B1 receptor. J Biol Chem 277 (2002) 16847-16852